Address
Contact
Tel: 0351 458 82052 Fax: 0351 458 82059 info@crt-dresden.de www.crt-dresden.deContact person
Cornelia ProbstFederico Calegari
Offer
DFG Center for Regenerative Therapies (CRTD),
Cluster of Excellence at the TU Dresden
The molecular biosciences provide unique prospects to enhance tissue and organ regeneration. Our goal is to develop advanced treatments for haemato-oncological, cardiovascular, neurodegenerative, diabetic and bone diseases.
Dresden has outstanding expertise in the life science disciplines (medicine, molecular cell- and developmental biology, stem cell research, genomics, proteomics, bioinformatics) and engineering (tissue engineering, biomaterials science, chemistry, nanotechnology), providing a fertile ground for a broad interdisciplinary effort towards developing regenerative therapies. Over 150 partners from science, economy, administration, culture, and finance form Biopolis, an innovative network for biomedical research. Scientific integration and synergy within the Biopolis is facilitated by the close location of participating institutes.
The DFG Research Center and Cluster of Excellence of the Technische Universitaet Dresden is capitalizing on basic and clinical research in regenerating model organisms and in patients to understand stem cell recruitment, activation, proliferation, homing and differentiation, and will apply this knowledge to control these cellular processes using genetics, surface engineering and microdevices in order to elicit regenerative responses.
The DFG-Center for Regenerative Therapies Dresden (CRTD) and Cluster of Excellence of the Technische Universität Dresden is a research institution aiming to explore the capacity for regeneration of the human body and to develop novel regenerative therapies in the fields of hematology/immunology, diabetes, neurodegeneration and bone and cartilage diseases. The institute was founded in 2006 and consists of 15 core groups and a network of over 90 members at several institutions in Dresden. In addition, 18 partners from industry are supporting the network. The synergies of the network allow for a fast translation of results from basic research to clinical applications.